Raffles Medical Group Ltd
RAFLF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $1,770 | $1,496 | $1,701 | $1,553 |
| - Cash | $334 | $334 | $344 | $344 |
| + Debt | $84 | $89 | $88 | $92 |
| Enterprise Value | $1,519 | $1,250 | $1,446 | $1,302 |
| Revenue | $189 | $189 | $193 | $193 |
| % Growth | 0% | -2.1% | 0% | – |
| Gross Profit | $87 | $87 | $87 | $87 |
| % Margin | 45.9% | 45.9% | 45.2% | 45.2% |
| EBITDA | $31 | $31 | $28 | $28 |
| % Margin | 16.5% | 16.5% | 14.2% | 14.2% |
| Net Income | $16 | $16 | $16 | $16 |
| % Margin | 8.5% | 8.5% | 8.2% | 8.2% |
| EPS Diluted | 0.009 | 0.009 | 0.009 | 0.009 |
| % Growth | 0% | 1.2% | 0% | – |
| Operating Cash Flow | $28 | $28 | $26 | $26 |
| Capital Expenditures | -$1 | -$1 | -$4 | -$4 |
| Free Cash Flow | $27 | $27 | $22 | $22 |